Neo: Int S/G2/M

Age: Up-Down-Down

Mlig455_008449 {REF} {Length: 3894} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=110.8]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=77.7]} {Human: ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=150, Expect=5e-40]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=152, Expect=1e-40]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=129, Expect=3e-32]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=142, Expect=3e-37]} {Smed: dd_Smed_v6_12182_0_1, dd_Smed_v6_12182_0_1, [Score=136, Expect=6e-35]} {RNA1509_7752} {RNA1310_10606.1} {RNA815_21386}

Mlig455_031351 {REF} {Length: 1459} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=110.3]; Neurotransmitter-gated ion-channel transmembrane region [PF02932.18, score=77.0]} {Human: ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=149, Expect=9e-39]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=150, Expect=2e-39]; ENSMUSG00000032303, Chrna3, cholinergic receptor, nicotinic, alpha polypeptide 3, [Score=144, Expect=6e-37]} {Dmel: FBgn0086778, nAChRalpha7, nicotinic Acetylcholine Receptor alpha7, [Score=130, Expect=3e-32]} {Celegans: WBGene00000055, acr-16, Acetylcholine receptor subunit alpha-type acr-16, [Score=140, Expect=4e-36]} {Smed: dd_Smed_v6_12182_0_1, dd_Smed_v6_12182_0_1, [Score=135, Expect=5e-34]} {RNA1509_7752} {RNA1310_10606.1} {RNA815_31438}

Mlig455_031363 {REF} {Length: 1072} {Pfam: Neurotransmitter-gated ion-channel ligand binding domain [PF02931.25, score=113.8]} {Human: ENSG00000147434, CHRNA6, cholinergic receptor nicotinic alpha 6 subunit, [Score=82.4, Expect=6e-17]; ENSG00000149305, HTR3B, 5-hydroxytryptamine receptor 3B, [Score=81.3, Expect=1e-16]; ENSG00000147432, CHRNB3, cholinergic receptor nicotinic beta 3 subunit, [Score=80.9, Expect=2e-16]; ENSG00000120903, CHRNA2, cholinergic receptor nicotinic alpha 2 subunit, [Score=79.0, Expect=7e-16]} {Mouse: ENSMUSG00000031491, Chrna6, cholinergic receptor, nicotinic, alpha polypeptide 6, [Score=83.6, Expect=1e-17]; ENSMUSG00000008590, Htr3b, 5-hydroxytryptamine (serotonin) receptor 3B, [Score=81.6, Expect=6e-17]; ENSMUSG00000022041, Chrna2, cholinergic receptor, nicotinic, alpha polypeptide 2 (neuronal), [Score=80.9, Expect=1e-16]; ENSMUSG00000031492, Chrnb3, cholinergic receptor, nicotinic, beta polypeptide 3, [Score=80.5, Expect=2e-16]} {Dmel: FBgn0000038, nAChRbeta1, nicotinic Acetylcholine Receptor beta1, [Score=75.1, Expect=8e-15]} {Celegans: WBGene00000057, acr-18, AcetylCholine Receptor; Acetylcholine receptor, one of nine alpha a7-like nicotinic acetylcholine receptor subunits (58.6 kD) (Acr-18), [Score=85.9, Expect=1e-18]} {Smed: dd_Smed_v6_30253_0_1, dd_Smed_v6_30253_0_1, [Score=80.9, Expect=4e-17]} {RNA1509_53098} {RNA1310_10606.2} {RNA815_31438}